Endocrine disrupting chemicals: a new and emerging public health problem?

Por Acerini, C L, Hughes, I A
Publicado em 2006

Hypertonic saline test for the investigation of posterior pituitary function

Por Mohn, A., Acerini, C., Cheetham, T., Lightman, S., Dunger, D.
Publicado em 1998

Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom

Por Todd, G, Acerini, C, Ross-Russell, R, Zahra, S, Warner, J, McCance, D
Publicado em 2002

Auxological changes in UK survivors of childhood acute lymphoblastic leukaemia treated without cranial irradiation

Por Breene, R A L, Williams, R M, Hartle, J, Gattens, M, Acerini, C L, Murray, M J
Publicado em 2011

Prenatal paracetamol exposure is associated with shorter anogenital distance in male infants

Por Fisher, B.G., Thankamony, A., Hughes, I.A., Ong, K.K., Dunger, D.B., Acerini, C.L.
Publicado no Hum Reprod (2016)

Measurement delay associated with the Guardian® RT continuous glucose monitoring system

Por Wei, C, Lunn, D J, Acerini, C L, Allen, J M, Larsen, A M, Wilinska, M E, Dunger, D B, Hovorka, R
Publicado em 2010

ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents

Por Dunger, D, Sperling, M, Acerini, C, Bohn, D, Daneman, D, Danne, T, Glaser, N, Hanas, R, Hintz, R, Levitsky, L, Savage, M, Tasker, R, Wolfsdorf, J
Publicado em 2004

Associations between a fetal imprinted gene allele score and late pregnancy maternal glucose concentrations

Por Petry, C.J., Mooslehner, K., Prentice, P., Hayes, M.G., Nodzenski, M., Scholtens, D.M., Hughes, I.A., Acerini, C.L., Ong, K.K., Lowe, W.L., Dunger, D.B.
Publicado no Diabetes Metab (2017)

Validity of triple- and dual-tracer techniques to estimate glucose appearance

Por Haidar, A., Elleri, D., Allen, J. M., Harris, J., Kumareswaran, K., Nodale, M., Acerini, C. L., Wilinska, M. E., Jackson, N., Umpleby, A. M., Evans, M. L., Dunger, D. B., Hovorka, R.
Publicado em 2012

Safety, efficacy and glucose turnover of reduced prandial boluses during closed‐loop therapy in adolescents with type 1 diabetes: a randomized clinical trial

Por Elleri, D., Biagioni, M., Allen, J. M., Kumareswaran, K., Leelarathna, L., Caldwell, K., Nodale, M., Wilinska, M. E., Haidar, A., Calhoun, P., Kollman, C., Jackson, N. C., Umpleby, A. M., Acerini, C. L., Dunger, D. B., Hovorka, R.
Publicado no Diabetes Obes Metab (2015)

Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects – expanding the clinical phenotype

Por Flanagan, S.E., Mackay, D. J. G., Greeley, S. A. W., McDonald, Timothy J., Mericq, V., Hassing, J., Richmond, E. J., Martin, W.R., Acerini, C, Kaulfers, A.M., Flynn, D.P., Popovic, J., Sperling, M.A., Hussain, K., Ellard, S., Hattersley, A.T.
Publicado em 2012

The Long-Term Outcome of Boys With Partial Androgen Insensitivity Syndrome and a Mutation in the Androgen Receptor Gene

Por Lucas-Herald, A., Bertelloni, S., Juul, A., Bryce, J., Jiang, J., Rodie, M., Sinnott, R., Boroujerdi, M., Lindhardt Johansen, M., Hiort, O., Holterhus, P. M., Cools, M., Guaragna-Filho, G., Guerra-Junior, G., Weintrob, N., Hannema, S., Drop, S., Guran, T., Darendeliler, F., Nordenstrom, A., Hughes, I. A., Acerini, C., Tadokoro-Cuccaro, R., Ahmed, S. F.
Publicado no J Clin Endocrinol Metab (2016)

Home Use of an Artificial Beta Cell in Type 1 Diabetes

Por Thabit, H., Tauschmann, M., Allen, J.M., Leelarathna, L., Hartnell, S., Wilinska, M.E., Acerini, C.L., Dellweg, S., Benesch, C., Heinemann, L., Mader, J.K., Holzer, M., Kojzar, H., Exall, J., Yong, J., Pichierri, J., Barnard, K.D., Kollman, C., Cheng, P., Hindmarsh, P.C., Campbell, F.M., Arnolds, S., Pieber, T.R., Evans, M.L., Dunger, D.B., Hovorka, R.
Publicado no N Engl J Med (2015)